News
Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases.
Healthcare & Pharmaceuticalscategory· December 20, 2024 Weight-loss drug developers line up to tap market worth $150 billion Novo Nordisk's ... June 3, 2024 Structure's obesity pill surpasses ...
Joining the consortium are Bristol Myers Squibb, COGNANO, Lambda, Novo Nordisk ... Design. Structure Therapeutics, headquartered in San Francisco, California, is a biotechnology company focused ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback